Skip to main content

Table 5 Acquired infectious complications

From: Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study

  GROUP A GROUP B GROUP C p value
(n = 52) (n = 53) (n = 52)
Number of infected patients 18/52 (34.6 %) 23/53 (43.4 %) 23/52 (44.2 %) 0.54
Odds ratio 1.4 (0.6–3.1)a 1.03 (0.4–2.2)c
1.4 (0.6–3.3)b
Infectious complication incidence rate / % treatment days 22/546 (4.03) 24/470 (5.11) 24/505 (4.75) 0.51
Catheter-related bloodstream infection 1/52 (1.92 %) 1/53 (1.89 %) 2/52 (3.85 %) 0.53
Primary bloodstream infection 3/52 (5.77 %) 1/53 (1.89 %) 3/52 (5.77 %) 0.25
UTI 1/52 (1.92 %) 1/53 (1.89 %) 1/52 (1.92 %) 1.00
Tracheobronchitis incidence rate / 1000 ventilator days 7/460 (15.2)*a 10/392 (25.5) 7/424 (16.5)*c <0.01*
VAP incidence rate / 1000 ventilator days 8/460 (17.3)*a 10/392 (25.5) 6/424 (14.1)*c <0.05*a
 < 0.01*c
  1. Values are provided as percentages (%) and incidence rate. Asterisks indicate statistical significance
  2. UTI urinary tract infection, VAP ventilator-associated pneumonia
  3. aDifference group A vs. group B
  4. bDifference group A vs. group C
  5. cDifference group B vs. group C